杨军芬,臧雁翔,李为民

• 1:哈尔滨医科大学附属第一医院心内科

摘要(Abstract)：

<正>左主干病变(left main coronary artery disease,LMCAD)指冠状动脉造影左主干狭窄程度≥50%的病变。左前降支近端以及左回旋支近端狭窄程度≥70%的病变被视为左主干等同病变[1]。EXCEL研究[2]与NOBLE研究[3]均是选择LMCAD患者作为研究对象的多中心随机对照试验(randomized controlled trial, RCT),而SYNTAX研究[4]、MAIN-COMPARE研究[5]中均有对LMCAD血运重建长期预后的分析,同时上述研究修改了欧美指南对LMCAD治疗的推荐等级,将经皮冠状动脉介入治疗(percutaneous coronary intervention,PCI)的等级

关键词(KeyWords)： 左主干病变;经皮冠状动脉介入治疗;冠状动脉旁路移植术;预后

Abstract:

Keywords:

基金项目(Foundation):

作者(Author): 杨军芬,臧雁翔,李为民

参考文献(References)：

• [1]Collet C,Capodanno D,Onuma Y,et al.Left main coronary artery disease:pathophysiology,diagnosis,and treatment.Nat Rev Cardiol,2018,15(6):321-331.
• [2]Kappetein AP,Serruys PW,Sabik JF,et al.Design and rationale for a randomised comparison of everolimus-eluting stents and coronary artery bypass graft surgery in selected patients with left main coronary artery disease:the EXCEL trial.Euro Intervention,2016,12(7):861-872.
• [3]M?kikallio T,Holm NR,Lindsay M,et al.Percutaneous coronary angioplasty versus coronary artery bypass grafting in treatment of unprotected lef t main stenosis(NOBLE):a prospective,randomised,open-label,non-inferiority trial.Lancet,2016,388(10061):2743-2752.
• [4]Morice MC,Serruys PW,Kappetein AP,et al.Five-year outcomes in patients with left main disease treated with either percutaneous coronary intervention or coronary artery bypass grafting in the synergy between percutaneous coronary intervention with Taxus and Cardiac Surgery Trial.Circulation,2014,129(23):2388-2394.
• [5]Park DW,Ahn JM,Yun SC,et al.10-year outcomes of stents versus coronary artery bypass grafting for left main coronary artery disease.J Am Coll Cardiol,2018,72(23 Pt A):2813-2822.
• [6]ESC Scientifi c Document Group.2018 ESC/EACTS guidelines on myocardial revascularization.Eur Heart J,2019,40(2):87-165.
• [7]Dehmer GJ,Blankenship JC,Cilingiroglu M,et al.SCAI/ACC/AHA expert consensus document:2014 update on percutaneous coronary intervention without on-site surgical backup.Circulation,2014,129(24):2610-2626.
• [8]Stone GW,Sabik JF,Serruys PW,et al.Everolimus-eluting stents or bypass surgery for left main coronary artery disease.N Engl JMed,2016,375(23):2223-2235.
• [9]Baron SJ,Chinnakondepalli K,Magnuson EA,et al.Quality-oflife after everolimus-eluting stents or bypass surgery for left-main disease:results from the EXCEL trial.J Am Coll Cardiol,2017,70(25):3113-3122.
• [10]Serruys PW,Cavalcante R,Collet C,et al.Outcomes after coronary stenting or bypass surgery for men and women with unprotected left main disease:the EXCEL Trial.JACC Cardiovasc Interv,2018,11(13):1234-1243.
• [11]Doucet S,Jolic?ur EM,Serruys PW,et al.Outcomes of left main revascularization in patients with acute coronary syndromes and stable ischemic heart disease:Analysis from the EXCEL trial.Am Heart J,2019,214:9-17.
• [12]Gershlick AH,Kandzari DE,Banning A,et al.Outcomes after lef t main percutaneous coronary intervention versus coronary artery bypass grafting according to lesion site:results from the EXCEL Trial.JACC Cardiovasc Interv,2018,11(13):1224-1233.
• [13]Chen S,Karmpaliotis D,Redfors B,et al.Does an occluded RCA affect prognosis in patients undergoing PCI or CABG for left main coronary artery disease?Analysis from the EXCEL trial.Euro Intervention,2019,15(6):e531-e538.
• [14]Giustino G,Mehran R,Serruys PW,et al.Left main revascularization with PCI or CABG in patients with chronic kidney disease:EXCELtrial.J Am Coll Cardiol,2018,72(7):754-765.
• [15]Kosmidou I,Chen S,Kappetein AP,et al.New-onset atrial fi brillation after PCI or CABG for left main disease:The EXCELTrial.J Am Coll Cardiol,2018,71(7):739-748.
• [16]Stone GW,Kappetein AP,Sabik JF,et al.Five-year outcomes after PCI or CABG for left main coronary disease.N Engl J Med,2019,381(19):1820-1830.
• [17]Holm NR,M?kikallio T,Lindsay MM,et al.Percutaneous coronary angioplasty versus coronary artery bypass graf ting in the treatment of unprotected left main stenosis:updated 5-year from the randomised,non-inferiority NOBLE trial.Lancet,2020,395(10219):191-199.
• [18]Thuijs DJFM,Kappetein AP,Serruys PW,et al.Percutaneous coronary intervention versus coronary artery bypass grafting in patients with three-vessel or left main coronary artery disease:10-year followup of the multicentre randomised controlled SYNTAX trial.Lancet,2019,394(10206):1325-1334.
• [19]Park SJ,Park DW,Ahn JM,et al.Ten-year outcomes after drugeluting stents versus coronary artery bypass grafting for left main coronary disease:extended follow-up of the PRECOMBAT Trial.Circulation,2020.[Epub ahead of print].